ECMC Announcement – National Lung Matrix Trial update

The National Lung Matrix Trial (NLMT) is a flagship precision medicine trial, funded by CRUK, and supported by the Stratified Medicine Programme Phase 2 (SMP2) screening platform. It is to our knowledge currently the largest precision medicine trial globally.